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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
1. To evaluate the effectiveness and safety of parent training programmes for managing colic in infants under four months of age.
2. To identify the educational content and attributes of such published programmes.
B A C K G R O U N D
Description of the condition
Infantile colic can be defined as periods of inconsolable, unex-
plained and incessant crying in a seemingly healthy infant that,
quite understandably, leads to exhausted, frustrated and concerned
parents seeking to comfort their child (Landgren 2010a).
The prevalence of excessive crying varies according to the defini-
tion used, although, most often, it peaks during the secondmonth
of life with a prevalence of 1.5% to 11.9% (Reijneveld 2001).
Traditionally, the definition of the condition was based on the
rule of three, that is, unexplained episodes of paroxysmal crying
for more than three hours per day, for three days per week, for at
least three weeks (Wessel 1954). More recently a new definition
has been proposed. It refers to a clinical condition of fussing and
crying for at least one week in an otherwise healthy infant (Hyman
2006). Rome III includes infantile colic, with diagnostic criteria
including all of the following in infants from birth to four months
of age: paroxysms of irritability, fussing or crying that starts and
stops without obvious cause; episodes lasting three or more hours
per day and occurring at least three days per week for at least three
weeks; and no failure to thrive (Mostafa 2008). Colic is a symptom
rather than a condition or diagnosis in and of itself.
The incidence of colic is estimated to be between 10% and 30%
of infants born (Clifford 2002; Rosen 2007). Paroxysms of incon-
solable crying are often accompanied by flushing of the face, me-
teorism (excessive flatulence in the intestinal tract with distention
of the abdomen), drawing up of the legs, and flatulence (Savino
2010). Symptoms have historically typically started in the second
week of life in both breast-fed and formula-fed infants and re-
solved by three months of age (Lucas 1998). Generally speaking,
these symptoms are not indicative of disease and thus hospital
admission for these infants is generally unnecessary, detrimental,
and should not be encouraged (Savino 2007). However, about 5%
of colicky crying infants do have a serious, underlying medical
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problem (Freedman 2009; Savino 2005; Savino 2007), and there
is evidence that older children presenting with migraine are more
likely to have been babies who have suffered colic (Romanello
2013). Therefore, all colicky infants should undergo a complete
medical assessment in order to exclude underlying medical condi-
tions which require investigation and treatment (Savino 2010).
The etiopathogenesis of infantile colic as a symptom remains un-
defined and is most likely multifactorial. Despite the common na-
ture of the condition, and the large amount of research investi-
gating this area, there have been no breakthroughs in terms of the
real mechanisms underlying infant colic.
It has been suggested that a number of behavioural factors (psy-
chological and social) and biological components (food hypersen-
sitivity, allergy, gut microflora, bloating from trapped gas and dys-
motility) can contribute to its manifestation (Gupta 2007). These
include the following.
First, lactose intolerance - due to a relative lactase deficiency -
has been identified as a possible causative factor in infant colic.
Carbohydrate malabsorption leads to the colonic fermentation of
sugars and an increase in the levels of hydrogen gas (Infante 2011).
The rapid production of hydrogen in the lower bowel distends
the colon, sometimes causing pain, whereas the osmotic pressures
generated by lactose and lactic acid in the colon cause an influx of
water, leading to further distension of the bowel. Although studies
evaluating the degree of hydrogen in the breath of colicky infants
have produced inconsistent results, increases in breath hydrogen
levels have been reported (Hyams 1989; Miller 1990; Moore
1998).
Second, the immunological model, which focuses on possible al-
lergens, has been suggested as a cause of colic. A key allergen is
cows’ milk proteins in breast milk or infant formula. Intact pro-
teins from the mother’s diet can sometimes cross over into the
breast milk and provoke an allergic response and symptoms of
colic in her infants. Consequently, a low-allergenmaternal diet, or
hypoallergenic infant formula (Iacovou 2012), has been proposed
as a form of treatment (Hill 2005; Schach 2002). The possibility
that infantile colic could be related to allergens was first described
by Shannon 1921. Since then a number of studies have evaluated
the possible association between colic and food hypersensitivity
(Heine 2013; Heine 2014; Hill 1995; Iacono 1991; Lothe 1982;
Merras-Salmio 2013; Saps 2011).
The evidence shows that about 25% of infants with moder-
ate or severe symptoms have cows’ milk protein-dependent colic
(Axelsson 1986; Hill 2000; Lindberg 1999), which improves af-
ter some days of a hypoallergenic diet (Campbell 1989; Dupont
2010; Estep 2000; Iacono 1991; Iacono 2005; Jakobsson 1983;
Jakobsson 2000; Lothe 1989; Savino 2001). For these infants, in-
fantile colic could be the first manifestation of atopic disease and,
for this reason, dietetic treatment should be the first therapeutic
approach (Gupta 2007; Hall 2012 ; Savino 2010). Indeed, di-
etary changes, such as eliminating cows’ milk proteins, are par-
ticularly indicated in cases of suspected intolerance to cows’ milk
proteins (e.g. in infants with a positive family history, eczema or
onset after the first month of life, and colic associated with other
gastrointestinal symptoms such as vomiting or diarrhoea) (Hill
1995; Hill 2005; Jakobsson 1983; Lucassen 2000; Savino 2014).
However, UpToDate 2016 grades the introduction of hydrolysate
formula for formula-fed infants or hypoallergenic diet for mothers
of breast-fed infants as a “2C”: “a very weak recommendation;
other alternatives may be equally reasonable”; “benefits and risks
may be finely balanced, or the benefits and risks may be uncer-
tain” and “the evidence comes from observational studies, unsys-
tematic clinical experience, or from randomised, controlled trials
with serious flaws”. A Cochrane review is underway to firm up the
evidence (Savino 2014).
Third, there is growing evidence that the intestinal microbiota
in colicky infants differ from those in non-colicky controls, since
higher levels of anaerobic bacteria, such as coliform and Es-
cherichia coli, microaerophilic bacteria, such as Helicobacter pylori
(Ali 2012), and a lower concentration of Lactobacilli have been
reported in infants with colic (Savino 2010). Human milk nat-
urally contains these prebiotics; they are defined as indigestible
oligosaccharides that could selectively enhance the proliferation of
certain probiotic bacteria in the colon, especially Bifidobacterium
species (Thomas 2010). Some studies have failed to find a pro-
tective effect of breast feeding on the development of colic in
breast-fed infants (Clifford 2002), however, it is unclear if these
studies compared exclusively breast-fed-from-birth infants with
exclusively artificially-fed-from-birth infants, and so it is still not
known whether any breastfeeding has some protective effect or
whether any artificial feeding compromises the infant gut micro-
biome in some way. Evidence suggests that oligosaccharide pre-
biotics (a mixture of galacto-oligosaccharides and fructo-oligosac-
charides) to encourage growth of the positive bacteria in the gut
may be effective treatments for allergy and food intolerance in
general (Arslanoglu 2012), and for crying in formula-fed infants
with colic in particular (Savino 2006). Microbiota diversity is sig-
nificantly lower in colicky infants and seems to decrease after birth
rather than being that way from birth (deWeerth 2013). Evidence
is building around the effectiveness of supplementing the infant’s
diet with probiotics to prevent colic and other symptoms (Oozeer
2013).
These three pathophysiological models indicate implicit treatment
modalities, however, various therapeutic interventions have been
used for infant colic that take a symptom-reduction, focused ap-
proach. These include pain relief (Savino 2002; Savino 2012);
probiotic supplementation (Indiro 2014); complementary and al-
ternative medicines and nutritional supplements such as fennel
extract (Harb 2015) and chamomile (Perry 2011); sucrose and
glucose solutions (Markestad 1997); and physical treatments such
as manipulation (Dobson 2012; Olafdottir 2001), massage and
reflexology (Huhtala 2000; Perry 2011). Although systematic re-
views have failed to provide evidence of its efficacy in reducing
colicky symptoms, by reducing trapped gas in the liquid of the
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stomach, simethicone is still often used (Metcalf 1994). Various
other physical treatments have been studied to reduce symptoms,
including carrying (Barr 1991), which may affect baby in psy-
chological or social ways, or address mechanical aspects such as
crib vibration (Huhtala 2000); and acupuncture (Landgren 2010a;
Landgren 2010b; Reinthal 2008; Skjeie 2013). Evidence of effi-
cacy is not comprehensive (Garrison 2000).
Description of the intervention
An alternate approach that has been investigated is to focus on
training, support and psychologically underpinned interventions
for parents of infants with colic.
There is recognition of the role of parental anxiety in the reported
incidence of colic and evidence that parental reassurance is success-
ful in reducing reports of distress (Furlong 2012; Hiscock 2014;
Taubman 1984; Taubman 1988; Wolfe 1994; Zwi 2011).
Guidance and informal education are often delivered by healthcare
professionals to accompany any intervention for infantile colic
so that parents and carers may better understand the potential
aetiologies and pursue various management and treatment options
(see, for example, Cook 2012). Parental behavioural modifications
have often been suggested both for breast-fed and formula-fed
infants, including advice to carry the infant (Barr 1991), not to
carry the infant (McKenzie 1991), and to try to understand the
infant’s needs (Taubman 1984).
Whilst there have been some attempts to synthesise evidence-in-
formed pathways for infantile colic that do include some parental
resources, for example, NICE (National Institute for Health
and Care Excellence) Clinical Knowledge Summaries, UpToDate
Patient Information Tips/health professional information and
Map of Medicine, it is well documented that the evidence base is
poor and inconclusive. Indeed, NICE CKS 2014 states that their
recommendations are pragmatic. There is currently no national or
international consensus on best practice for such interventions.
How the intervention might work
Clearly such interventions do not address underlying pathology
such as cows’ milk protein allergy, gastro-oesophageal reflux, etc.
However, there is a substantial infant population suffering from
colic with no clear identifiable cause, who are known to have a
natural history that will lead to symptom reduction by six months
of age (Parkin 1993; St James-Roberts 1991). Parents have little
firm idea of what will and what will not work (Oshikoya 2009),
and so they try lots of potential solutions with variable results,
which is extremely stressful for both baby and parents.
Many parent training programmes are focused on reassurance of
the natural symptom reduction in time and explanation of some
soothing strategies to reduce parental anxiety. This is believed to
be important as parental anxiety can, in turn, reduce effectiveness
of soothing strategies and increase the perceived impact of symp-
toms. Additionally, they seek to offer education on such soothing
strategies or on understanding baby’s potential needs in a manner
that is consistent and in line with best practice to reduce con-
flicting messages, and offer a source of information that is not
readily available to parents: baby often needs soothing or comfort
rather thanmore feed, different feed, medicating, etc., and parents
should be aware of the stress of a crying baby and seek to soothe
themselves to avoid harming the child (Bryanton 2013; Chandran
2014; Levy 2015; Reijneveld 2001; Schmitt 1987). This combi-
nation of reassurance as to the natural history of symptom reso-
lution, a consistent single set of messages regarding management
advice, and explanation that a less anxious parent can reduce colic
in the infant, will have two actions. First, it will ensure the in-
fant gets the most appropriate soothing techniques in a consistent
manner to reduce their symptoms. Second, it will reduce anxiety
in parents, enhancing their satisfaction, quality of life and poten-
tially improving their ability to deliver the soothing strategies.
Why it is important to do this review
There is no clarity as to the extent these components contribute to
the overall efficacy of symptom reduction strategies or to parental
anxiety levels. Some interventions have been ineffective such as
the McRury 2010 study based on techniques found in a popular
parenting book - The Happiest Baby - by Karp 2003. Given the
clinical and methodological heterogeneity of studies on these in-
terventions, the efficacy of these interventions in reducing infant
colic remains inconclusive, at present.
Established studies and reports may now be outdated (e.g. Schmitt
1987; Taubman 1984), and more recent reported approaches are
based on different approaches (e.g.Hiscock 2014 is based on an in-
tervention described in Cook 2012; Keefe 2005), and so an up-to-
date systematic review using Cochrane methodology is required.
It is also important to note that focus within the published body of
work often seeks to assess ’whether’ such training is effective (e.g.
Hiscock 2014), and this can be considered of limited educational
research value (Norcini 2011). This is important as, in this con-
text, the intervention being considered is educational, and if this
cannot be defined, it cannot be reliably and validly reproduced and
disseminated in a systematic fashion. Therefore, equally relevant
questions are ’how’ it achieves this outcome, ’why’ the teaching is
effective and ’for whom and when’ such training can be effective.
A review and synthesis of the evidence must also address these
items and, from an educational stance, identify a relevant theory
from this evidence base (Haji 2013). This will support future pro-
fessionals in understanding and delivering such an intervention
in a reliable and reproducible manner. Even if such data are not
explicit within primary studies, synthesis can highlight such out-
comes, as has been increasingly shown in the field of health edu-
cation (Gordon 2011; Gordon 2013).
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This review sets out to consider the effectiveness of parent training
programmes (when compared to other interventions), the safety
of such programmes, and to identify the content and attributes
underpinning such programmes.
O B J E C T I V E S
1. To evaluate the effectiveness and safety of parent training
programmes for managing colic in infants under four months of
age.
2. To identify the educational content and attributes of such
published programmes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs.
Types of participants
Infants younger than four months of age who are already suffering
from infantile colic as defined by the study, for example, Rome
III (Mostafa 2008) or Wessel (Wessel 1954). Both breast-fed and
formula-fed infants will be eligible.
Types of interventions
Any form of parental training programmes, alone or in combina-
tion, versus another intervention(s) or placebo. Examples of pro-
gramme content may include:
1. normalisation material in any form;
2. soothing techniques; and
3. feeding management advice.
In the teaching forms of:
1. face-to-face courses;
2. online and e-learning;
3. printed materials;
4. home visits and coaching; and
5. remote support and counselling.
Types of outcome measures
For all proposed outcomes, we will use the final outcomes from the
end of the trials, and we will record the timings of these outcomes
as they may guide the subgroup analysis (see Subgroup analysis
and investigation of heterogeneity).
Primary outcomes
1. A reduction in the duration of crying (post-treatment
versus baseline). Data may be continuous (e.g. hours per day), or
dichotomous (e.g. reduction under a predefined threshold, as
determined by the trial authors).
2. Adverse effects, including parental depression and mental
illness, choking, apparent life-threatening events (dichotomous
outcome).
Secondary outcomes
1. The number of responders in each group after treatment:
reduction in frequency of crying episodes per 24 hours (post-
treatment versus baseline) (dichotomous outcome, as defined by
the primary studies).
2. Parental or family quality of life, including measures of
parental stress, anxiety or depression, as proposed by the primary
studies and so no single scale may be possible (continuous
outcome).
3. Infant sleep duration per 24 hours at seven, 14, and 21 days
(post-treatment versus baseline) (continuous outcome).
Search methods for identification of studies
We will identify relevant trials by searching the sources described
below.
Electronic searches
Wewill search the following electronic databases and trial registers
from inception onwards:
1. Cochrane Central Register of Controlled Trials
(CENTRAL; current issue) in the Cochrane Library, which
includes Cochrane Developmental, Psychosocial and Learning
Problems Specialised Register;
2. MEDLINE Ovid (1946 to date);
3. MEDLINE In-Process and Other Non-Indexed Citations
Ovid (current issue);
4. MEDLINE Epub Ahead of Print Ovid (current issue);
5. Embase Ovid (1980 to date);
6. CINAHL Plus EBSCOhost (Cumulative Index to Nursing
and Allied Health Literature; 1937 to date);
7. PsycINFO Ovid (1967 to date);
8. Science Citation Index - Expanded Web of Science (SCI;
1970 to date);
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9. Social Sciences Citation Index Web of Science (SSCI; 1970
to date);
10. Conference Proceedings Citation Index - Science Web of
Science (CPCI-S; 1990 to date);
11. Conference Proceedings Citation Index - Social Science and
Humanities Web of Science (CPCI-SSH; 1990 to date);
12. LILACS (Latin American and Caribbean Health Science
Information database; lilacs.bvsalud.org/en);
13. Cochrane Database of Systematic Reviews (CDSR; current
issue) in the Cochrane Library;
14. Database of Abstracts of Reviews of Effects (DARE; current
issue) in the Cochrane Library;
15. Epistemonikos (limited to systematic reviews;
epistemonikos.org);
16. WorldCat (limited to theses; worldcat.org);
17. US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (clinicaltrials.gov); and
18. World Health Organization International Clinical Trials
Registry Platform (WHO ICTRP; apps.who.int/trialsearch).
We will search MEDLINE using the search strategy in Appendix
1, which uses the sensitivity maximizing version of the Cochrane
Highly Sensitive Search Strategy for identifying randomised trials
(Lefebvre 2008).Wewill adapt this strategy for other databases.We
will not impose any date or language restrictions. Studies published
in languages other than English will be professionally translated
in full.
Searching other resources
Grey literature
To assess more contemporaneous studies that have not yet been
published in full, we will handsearch abstracts presented at relevant
international meetings, including the European Society for Paedi-
atric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
and the North American Society for Paediatric Gastroenterology,
Hepatology and Nutrition (NASPGHAN), published from 2010
onwards. There is some evidence that data from abstracts can be
inconsistent with data in published articles (Pitkin 1999). There-
fore, we will only include abstract publications if sufficient data
are presented to judge inclusion and assess quality. Where such
data are not presented, we will attempt to contact authors for more
information, and meanwhile will place the studies in ’Awaiting
classification’.
Reference searching
We will inspect the references of included studies for more trials.
We will search the bibliographies of included studies to identify
any other potentially relevant articles.
Personal contacts
Wewill contact leaders in the field to try to identify other published
and unpublished studies.
Data collection and analysis
Selection of studies
Two review authors (Morris Gordon (MG) and Shel Banks (SB))
will independently screen titles, abstracts, and full reports for eli-
gibility against the inclusion criteria (see Criteria for considering
studies for this review). Specifically, they will:
1. merge search results using reference management software
and remove duplicate records of the same report;
2. examine titles and abstracts to remove irrelevant records;
3. retrieve full texts of potentially relevant reports;
4. link together multiple reports of the same study;
5. examine full-text reports for studies that meet the eligibility
criteria;
6. correspond with investigators, when appropriate, to clarify
study eligibility;
7. at all stages, note reasons for inclusion and exclusion of
reports on a study flow spreadsheet, resolving any disagreements
through consensus;
8. make final decisions on study inclusions and resolve any
discrepancies through a process of consensus; and
9. proceed to data collection.
Wewill record our selection process in a PRISMAdiagram (Moher
2009).
Data extraction and management
We will develop data extraction forms a priori, as per the recom-
mendations in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011a).We will extract the information de-
scribed below.
1. Characteristics of participants: source of participants,
inclusion and exclusion criteria, total number at baseline, total
number at completion, setting, definition of ’colic’ applied,
diagnostic criteria applied, type of feeding (breast feeding,
formula feeding), age at onset of colic, age at commencement of
intervention, and evaluation of potential effect modifiers (e.g.
age, gender).
2. Characeristics of intervention: content of training,
pedagogical methods employed, context, resources and educator
details, any theoretical underpinning described.
3. Interventions and controls: number of groups,
intervention(s) applied, frequency and duration of treatment,
total number of treatments, permitted cointerventions.
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4. Methods: study design, duration, sequence generation,
allocation concealment, blinding of outcome assessors,
evaluation of success of blinding.
5. Outcomes: list of outcomes assessed, definitions used,
values of means and standard deviations (SDs) at baseline and at
time points as defined by the study protocol (or change from
baseline measures, if given).
6. Results: measures at end of protocol, follow-up data
(including means and SDs, standard errors, or confidence
intervals (CI) for continuous data, and summary tables for
dichotomous data), withdrawals, and losses to follow-up.
7. Other: references to other relevant studies, points to follow
up with authors, comments from the authors, key conclusions
from the study (by the authors), other comments from review
authors.
Two review authors (MG and SB) will extract the data inde-
pendently using the data extraction form. A third review author
(Megan R Thomas (MRT)) will resolve any disagreements. We
will collate data in the latest version of Review Manager 2014.
Assessment of risk of bias in included studies
Two review authors (MG and SB) will independently evaluate
each study for risk of bias using the criteria recommended in the
Cochrane Handbook for Systematic Reviews of Interventions (Deeks
2011; Higgins 2011b) for the following domains: sequence gener-
ation; allocation concealment; blinding of parents and health pro-
fessionals, blinding of outcome assessment; incomplete outcome
data; selective outcome reporting; and other potential threats to
validity. We will judge each domain as being at ’low’, ’high’, or
’unclear’ risk of bias. We will compare the judgments, and discuss
and resolve any inconsistencies in the assessments. A third review
author (MRT) will resolve any persisting disagreements. We will
complete a ’Risk of bias’ table for each included study and present
the ’Risk of bias’ summary graphically.
Sequence generation
We will include only RCTs or quasi-RCTs in this review. We will
assess randomisation as being at low risk of bias if the procedure
of sequence generation was explicitly described to confirm it was
random; examples include computer-generated random numbers,
a random numbers table or coin-tossing. If no description is given,
we will contact the authors for further information and if we fail
to receive a response, we will assign a judgment of unclear risk of
bias. We will consider studies that use non-randomised procedures
to be at high risk of bias.
Allocation concealment
We will assess concealment of treatment allocation as being at low
risk of bias if the procedure was explicitly described and adequate
efforts weremade to ensure that intervention allocations could not
have been foreseen in advance of, or during, enrolment; examples
include centralized randomisation, numbered or coded containers,
or sealed envelopes. Procedures considered to have a high risk of
bias include alternation or reference to case record numbers or
dates of birth. We will also assign a high risk of bias if allocation
concealment did not occur, as intervention allocations could have
been foreseen and thus introduced potential bias. If no description
is given, we will contact the study authors and if no response is
received, we will assign a judgment of unclear risk of bias.
Blinding of parents and health professionals
In this context, the intervention is administered by parents and so,
in effect, they will be considered the target of the blinding proce-
dures. Indeed, as the participants will be less than four months of
age by the defined inclusion criteria, it is deemed that this item is
not applicable to them. Furthermore, parents often act as outcome
assessors. We will primarily assess the risk of bias associated with
the blinding of parents of participants based on the likelihood
that such blinding was sufficient to ensure that parents had no
knowledge as to which intervention they, on behalf of the infant,
received.
Blinding of outcome assessment
We will describe, for each included study, the methods used, if
any, to blind the outcome assessors from knowledge of which
intervention a participant received. We will judge studies to be at
low risk of bias if they were blinded or if we consider that the lack
of blinding could not have affected the results. If blinding was
not done, or not possible due to the nature of intervention, we
will judge the study to be at high risk of bias because it is possible
that the lack of blinding influenced the results. If no description is
given, we will contact the study authors for more information, and
if we do not receive a response, wewill assign a judgment of unclear
risk of bias. We will note the blinding of health professionals, if
reported.
Incomplete outcome data
Incomplete outcome data essentially include attrition, exclusions,
and missing data.
We will assign a judgment of low risk of bias if:
1. participants included in the analysis are exactly those who
were randomised into the trial, if missing outcome data are
balanced in terms of numbers across intervention groups with
similar reasons for missing data across groups, or if there are no
missing outcome data;
2. for dichotomous outcome data, the proportion of missing
outcomes compared with observed event risk is not sufficient to
have a clinically relevant impact on the intervention effect
estimate;
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3. for continuous outcome data, the plausible effect size
(standardized mean differences (SMD)) among missing
outcomes is not sufficient to have a clinically relevant impact on
observed effect size; or
4. missing data have been imputed using appropriate methods.
We will assign a judgment of high risk of bias when:
1. reasons for missing outcome data are likely to be related to
the true outcome, with either an imbalance in numbers or
reasons for missing data across intervention groups;
2. for dichotomous outcome data, the proportion of missing
outcomes compared with observed event risk is sufficient to
induce clinically relevant bias in the intervention effect estimate;
3. for continuous outcome data, the plausible effect size
(SMD) among missing outcomes is sufficient to induce clinically
relevant bias in the observed effect size;
4. an ’as-treated’ analysis is carried out in cases where there is
substantial departure of the intervention received from that
assigned at randomisation;
5. there is a potentially inappropriate application of simple
imputation; or
6. the dropout rate is reported as higher than 20%, since there
is evidence that dropout rates higher than 20% are likely to
increase bias in treatment estimates (Unnebrink 2001; Wright
2003).
We will assign a judgment of unclear risk of bias when:
1. there is insufficient reporting of attrition or exclusions, or
both, to permit a judgment of low or high risk of bias;
2. the study reported incomplete outcome data; or
3. the numbers randomised to intervention and control
groups are not clearly reported.
Selective outcome reporting
We will assess the reporting of outcomes as being at low risk of
bias if all the study outcomes declared in the methods section
have been reported in the results. We will also evaluate whether
different reports of the study are available, including protocols,
and examine them to ensure there is no suggestion of selective
outcome reporting. If no description is given, we will contact the
authors for more information and if no response is received, we
will assign a judgment of unclear risk of bias. If there is evidence
of selective reporting (such as a significant departure from the
protocol or key outcomes that were due to be investigated are not
reported), we will assign a judgment of high risk of bias.
Other potential threats to validity
If the study is at risk of other sources of bias, we will assess it as
being at high risk of bias. For instance, if it was stopped early due
to a data-dependent process, having a baseline imbalance between
the groups, or sources of sponsorship or funding.Wewill assess the
study as being at low risk of bias if it appears to be free from such
threats to validity. When the risk of bias is unclear from published
information, we will attempt to contact authors for clarification.
If this is not forthcoming, we will assess these studies as being at
unclear risk of bias.
Measures of treatment effect
Dichotomous data
We will present dichotomous data as risk ratios (RR), since the
effects of the RR are readily understood (Walter 2000). We will
report all dichotomous data with their associated 95% CI and
probabilities of control and treatment groups (where possible).
Continuous data
If all studies use the same measurement scale, we will calculate
mean differences (MD) for change scores. Where studies use dif-
ferent scales, we will calculate the SMD using Hedges’ (adjusted)g.
If necessary, we will calculate effect estimates from P values, t-
statistic, analysis of variance (ANOVA) tables, or other statistics
as recommended in the Cochrane Handbook for Systematic Reviews
of Interventions (Deeks 2011).
For this analysiswewill use, according to need, either change scores
or final values, without combining them: we will not combine
these two different indices in meta-analysis and will only meta-
analyse homogeneous data sets.
If both continuous and dichotomous data are available for an out-
come, we will include only the continuous outcome in the primary
analysis. If some studies report an outcome as a dichotomous mea-
sure, and others use a continuous measure of the same construct,
we will convert the results for the former from the dichotomous
measure to a SMD, provided that we can assume the underlying
continuous measure has approximately a normal or logistic distri-
bution (otherwise we will carry out two separate analyses).
Unit of analysis issues
Cluster-randomised trials
For each included study, we will determine whether the unit of
analysis is appropriate for the unit of randomisation and the design
of that study (that is, whether the number of observations matches
the number of ’units’ that were randomised (Deeks 2011)). It is
unlikely that we will find cluster-randomised trials because this
design is uncommon in this field. However, if we do, we will use
the intraclass correlation coefficient (ICC) to convert trials to their
effective sample size before incorporating them into the meta-
analysis, as recommended in theCochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011b). When the ICC cannot
be used, wewill use values available in the published literature as an
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external source, when available, as well as contacting the author to
supply more data to allow an estimate of the ICC to be calculated
(Campbell 2000).
Studies with multiple treatment arms
In the primary analysis, we will combine results across all eligi-
ble intervention arms (parent training programmes, i.e. courses
or written materials), and compare them with the combined re-
sults across all eligible control arms (another intervention(s) or
placebo),making single, pairwise comparisons.Where such a strat-
egy prevents investigation of potential sources of heterogeneity, we
will analyse each programme type separately (against a common
control group - placebo), but divide the sample size for common
comparator arms proportionately across each comparison (Higgins
2011b). This simple approach allows the use of standard software
(including Review Manager 2014), and prevents the inappropri-
ate double-counting of individuals.
Cross-over studies
In randomised cross-over studies, individuals receive each inter-
vention sequentially, in a random order. Cross-over studies usually
contain a washout period, which is a stage after the first treatment
but before the second treatment, where time is given for the active
effects of the first treatment to wear off before the new treatment
begins (that is, to reduce the carry-over effect). A concern with
the cross-over design is the risk of a carry-over effect, when the
first treatment affects the second, and this is of particular concern
given the educational nature of the interventions being assessed.
For this review, we will not include any data in cross-over studies
after the first treatment period.
Qualitative analysis
For qualitative outcomes, wewill avoidmaking a priori hypotheses
and conclusions, in keeping with a grounded theory approach.
Following collection and processing, two review authors (MG and
SB) will code the data using Nvivo 2015. An initial thematic
index will be developed, with the addition of emerging thematic
categories according to interpretation of the content of the data.
The analysis will proceed through three stages consisting of open,
axial and selective coding, with constant comparison taking place
throughout each phase. Each stage will provide categories that
could be used to explore the themes of the data and build an
interpretation that can address the overarching research questions.
To clarify, as per the section on Types of outcome measures above,
studies that are qualitative reports of parent training programmes,
with no quantitative assessment, will not be included. Rather,
extraction and synthesis of qualitative data of the intervention
itself will be performed.
Dealing with missing data
Where data are missing, we will contact the corresponding au-
thors of included studies to supply any unreported data. For all
outcomes, in all studies, we will carry out analyses as far as possible
on an intention-to-treat basis; that is, we will attempt to include
all participants randomised to each group in the analyses, and we
will analyse all participants in the group to which they were al-
located, regardless of whether or not they received the allocated
intervention. For missing statistics (missing SDs), we will estimate
SDs from other available data, such as standard errors, or we will
impute them using the methods suggested in Higgins 2011b. We
will make no assumptions about loss to follow-up for continuous
data, and we will base analyses on those participants completing
the trial. If there is a discrepancy between the number randomised
and the number analysed in each treatment group, we will cal-
culate and report the percentage lost to follow-up in each group.
Where it is not possible to obtain missing data, we will record this
in the data collection form, report it in the ’Risk of bias’ table, and
discuss the extent to which the missing data could alter the results
and hence the conclusions of the review. For included studies, we
will note levels of attrition.Wewill explore the impact of including
studies with high levels of missing data in the overall assessment of
treatment effect by conducting sensitivity analyses (see Sensitivity
analysis).
Assessment of heterogeneity
Wewill assess clinical heterogeneity by comparing the distribution
of important participant characteristics between trials (e.g. age)
and trial characteristics (e.g. randomisation, concealment, blind-
ing of outcome assessment, losses to follow-up, treatment type,
cointerventions). We will assess statistical heterogeneity by exam-
ining the I2 statistic (Deeks 2011), a quantity that describes the
proportion of variation in point estimates that is due to variability
across studies rather than sampling error. We will interpret the I2
statistic as suggested in the latest version of Deeks 2011:
1. 0% to 40%: might not be important;
2. 30% to 60%: may represent moderate heterogeneity;
3. 50% to 90%: may represent substantial heterogeneity; or
4. 75% to 100%: suggests considerable heterogeneity.
We will employ a Chi2 test of homogeneity, with a 10% level of
significance, to determine the strength of evidence that hetero-
geneity is genuine. We will also report Tau2.
Once data have been extracted, clinical and methodological het-
erogeneity will be judged by discussion between authors (see
Subgroup analysis and investigation of heterogeneity).
Assessment of reporting biases
In order to minimize publication bias, we will attempt to obtain
the results of any unpublished studies in order to compare the
results extracted from published journal reports with the results
obtained from other sources (including correspondence).
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In addition, if there are more than 10 studies grouped in a com-
parison, we will evaluate whether reporting biases are present by
using funnel plots to investigate any relationship between effect
estimates and study size or precision, or both, as recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
(Sterne 2011).
Data synthesis
Where interventions are similar in type of parental training pro-
gramme and type of outcome assessed, we plan to group the stud-
ies and synthesize their results in a meta-analysis. We will present
results for each combination of parental training programme, as-
sessed outcome and colic type, with the exception of those studies
for which no data are observed. For instance, if two ormore studies
assess the effects of a parental training programme for parents of
otherwise healthy children with colic and both measure the daily
crying, we will perform a meta-analysis of the results. Because
we assume that clinical heterogeneity is very likely to impact on
our review results, given the wide breadth and types of interven-
tions included, we will combine the studies using a random-effects
model, regardless of evidence of statistical heterogeneity. We will
calculate all overall effects using inverse variance methods. We will
carry out statistical analysis using Review Manager 2014. Where
data are insufficient to allow meta-analysis or qualitative analysis,
we will provide a narrative synthesis and descriptive summary of
the study outcomes.
While there may be heterogeneity in the interventions, as well as
the comparisons, we consider that the consensus on definitions of
symptoms for eligibility manages the risk of ’blurring’ the results.
However, we remain vigilant and if a risk is perceived upon evalu-
ation of our findings, a sensitivity analysis removing such trials to
provide more definite findings may be required.
Subgroup analysis and investigation of heterogeneity
Large numbers of subgroup analyses may lead to misleading con-
clusions (Oxman 1992; Yusuf 1991). We plan to carry out the
following subgroup analyses:
1. type of feeding (bottle-fed versus breast-fed);
2. short-term and long-term follow-up (four weeks or less
versus more than four weeks of treatment);
3. type of parental training (face-to-face versus distance or
written materials); and
4. crying time in consideration with infant’s age.
These analyses will be exploratory as they will involve non-experi-
mental (cross-study) comparisons on primary outcomes only. We
will treat any conclusions with caution.
Sensitivity analysis
Wewill conduct sensitivity analyses to determine whether findings
are sensitive to:
1. trials with low levels of potential bias versus trials with high
levels of potential bias;
2. missing information or missing results (using 20% attrition
as ’high risk’ of bias, see above);
3. the definition of colic used, by conducting analyses on
studies using the stringent Wessel definition of infant colic
(Wessel 1954), the more recent definition given by Hyman
2006, and a non-recognized definition; and
4. the choice of model used, by comparing results from the
random-effects model, which we are using, with those from the
fixed-effects model.
Presentation of main results
We will assess the overall quality of evidence using the GRADE
approach (Guyatt 2008). We will present the results of our as-
sessment in a ’Summary of findings’ table, per comparison, cre-
ated using GRADEpro GDT software (GRADEpro GDT 2014).
The comparisons used will be those outlined in the studies, and
so may be another intervention(s) or placebo. Our table will in-
clude information on the type of participants, the interventions
and comparisons used in each case, and the outcomes and their
measurements for each study, as well as the setting and the length
of follow-up. The GRADE approach appraises the quality of a
body of evidence based on the extent to which one can be con-
fident that an estimate of effect, or association, reflects the item
being assessed. RCTs start as high-quality evidence but may be
downgraded due to: risk of bias (methodological quality), indirect-
ness of evidence, unexplained heterogeneity, imprecision (sparse
data), and publication bias. Intention-to-treat data would be of
better quality than per protocol results. Two review authors (SB
and MG) will independently assess and agree the overall quality
of the evidence for each outcome after considering each of these
factors, and will grade them as:
1. high quality: further research is very unlikely to change
confidence in the estimate of effect;
2. moderate quality: further research is likely to have an
important impact on confidence in the estimate of effect, and
may change the estimate;
3. low quality: further research is very likely to have an
important impact on confidence in the estimate of effect, and is
likely to change the estimate; or
4. very low quality: any estimate of effect is very uncertain.
We will include any rationale for the downgrading of the quality
of the evidence in the footnotes of the table
We will take the assumed risk from the median of the risk in the
control groups amongst included studies.Wewill use the following
outcomes:
1. a reduction in the duration of crying (post-treatment versus
baseline);
2. adverse effects, including parental depression and mental
illness, choking, apparent life-threatening events;
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3. the number of responders in each group after treatment:
reduction in frequency of crying episodes per 24 hours (post-
treatment versus baseline);
4. parental or family quality of life, including measures of
parental stress, anxiety or depression, as proposed by the primary
studies and so no single scale may be possible; and
5. infant sleep duration per 24 hours at seven, 14, and 21 days
(post-treatment versus baseline).
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1 colic/
2 colic$.tw.
3 ((stomach or abdominal or abdomen$) adj3 (spasm$ or pain$ or cramp$)).tw.
4 ((gastric or gastro$) adj3 (spasm$ or pain$ or cramp$)).tw.
5 crying/
6 (cry or crying or cries).tw.
7 or/1-6
8 exp Infant/
9 (baby or babies or infant$ or child$ or newborn$ or neonat$).tw.
10 or/8-9
11 7 and 10
12 exp Parents/
13 Parenting/
14 exp Parent-Child Relations/
15 family relations/
16 exp maternal behavior/
17 maternal deprivation/
18 paternal behavior/
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19 paternal deprivation/
20 (parent$ or mother$ or father$ or maternal$ or paternal$ or famil$).tw.
21 or/12-20
22 Health Education/
23 education/
24 teaching/
25 (class$ or coach$ or counsel$ or curricul$ or educat$ or group$ or intervention$ or learn$ or package$ or program$ or support$
or teach$ or train$).tw.
26 or/22-25
27 21 and 26
28 exp Parents/ed [Education]
29 ((home$ or nurse$ or famil$ or mother$ or parent$ or father$) adj2 visit$).tw.
30 or/27-29
31 11 and 30
32 randomized controlled trial.pt.
33 controlled clinical trial.pt.
34 randomi#ed.ab.
35 placebo$.ab.
36 drug therapy.fs.
37 randomly.ab.
38 trial.ab.
39 groups.ab.
40 or/32-39
41 exp animals/ not humans.sh.
42 40 not 41
43 31 and 42
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